Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Orthop Res. Author manuscript; available in PMC 2011 September 1.
Published in final edited form as:
PMCID: PMC2891234

Chronic axial compression of the mouse tail segment induces MRI bone marrow edema changes that correlate with increased marrow vasculature and cellularity


MRI of bone marrow edema (BME) has been found to be helpful in the diagnosis of back pain attributed to degenerative disk disease (DDD) and spondyloarthropathy (SA), but its interpretation is limited by a lack of knowledge of its nature and natural history. To address this, we assessed effects of compressive forces to mouse tail segments of WT and TNF-Tg mice with SA, via contrast enhanced MRI and histology. Normalized marrow contrast enhancement (NMCE) of uninstrumented WT vertebrae significantly decrease 3-fold (p<0.01) from 8 to 12 weeks of age, consistent with red to yellow marrow conversion, while the NMCE of TNF-Tg vertebrae remained elevated. Chronic compressive loading 6X body weight to WT tails increased NMCE 2-fold (p<0.02) within 2-weeks, which was equal to 6X loaded TNF-Tg tails within 4-weeks. Histology confirmed degenerative changes and that load-induced NMCE corresponded to increased vascular sinus tissue (35± 3% vs. 19± 3%; p<0.01) and cellularity (4,235± 886 vs.1,468± 320 cells/mm2; p<0.01) for the loaded vs. unloaded WT respectively. However, micro-CT analyses failed to detect significant load-induced changes to bone. While the bone marrow of loaded WT and TNF-Tg vertebrae were similar, histology demonstrated mild cellular infiltrate and increased osteoclastic resorption in the WT tails versus severe inflammatory-erosive arthritis in TNF-Tg joints. Significant (p<0.05) decreases in cortical and trabecular bone volume in uninstrumented TNF-Tg vs. WT vertebrae were confirmed by micro-CT. Thus, chronic load-induced DDD causes BME signals in vertebrae similar to those observed from Ankylosing Spondylitis (AS), and both DDD and AS signals correlate with a conversion from yellow to red marrow, with increased vascularity.

Keywords: Modic Changes, CE-MRI, Bone Marrow Edema, Vertebral Degeneration


Low back pain (LBP) which may be associated with degenerative disk disease (DDD) remains a major public health problem, and has an annual incidence in the adult population of 10–15%, and a point prevalence of 15–30%.1 Of those patients suffering from back pain 70% will seek medical care, making it the second most common reason for visiting a physician’s office.2,3 Individuals with LBP have per capita healthcare expenditures about 60% larger than individuals who do not suffer from LBP.4 However, despite its great prevalence, there is no clinical consensus on the treatment for this condition. 5 Thus, there is a need for basic research to elucidate the molecular mechanisms responsible for LBP, and to develop objective translational outcome measures that can quantify painful pathology.

Recently there have been attempts at classifying LBP into treatment response categories, however, these categories have yet to be definitively validated.6,7 One outcome measure that is widely utilized for these clinical decisions is the presence of inflammation, or bone marrow edema (BME) observed on MRI,8 commonly referred to as “Modic Type 1 (MT1) and Type 2 (MT2) changes.”9,10 MT1 changes appear as decreased signal intensity on T1-weighted spin-echo images and increased signal intensity on T2-weighted images, while MT2 changes are defined as increased signal intensity on T1-weighted images and isointense or slightly increased signal intensity on T2-weighted images.9,10 Although there are exceptions to the rules,11 the consensus has been that there is some relationship between MT1 and discogenic pain.12,13 At the molecular level, other studies have demonstrated that vertebral endplates from DDD patients with MT1 changes have significantly more tumor necrosis factor (TNF) immunoreactive cells versus controls,14 and phase I clinical trials investigating anti-TNF agents as a treatment for severe sciatica15 and lumbosacral radiculopathy16 have shown promising results. Interestingly, patients with painful spondyloarthropathies (SA) like ankylosing spondylitis (AS), also present with BME signal on MRI.17 Moreover, efficacy of FDA approved anti-TNF therapy in these patients has been correlated with amelioration of BME,17 and significant improvements in productivity and workday loss.18 While these remarkable clinical findings support the theory that TNF-induced BME is the long-sought-after objective biomarker of LBP, a cost-effective animal model is still needed to: 1) formally characterize the natural history of BME in the DDD and SA, 2) determine the cellular and biochemical nature of BME, and 3) test hypotheses regarding the cause-effect relationship between DDD, BME and LBP.19 Thus, to the end of understanding the direct relationship between vertebral compression and the genesis of BME via conversion of fatty “yellow” to haematopoietic “red” bone marrow, here we test the hypothesis that chronic axial compression of the mouse tail segment induces BME signal changes seen on CE-MRI that correlate with increased marrow vasculature and cellularity. This small animal model combines high resolution contrast enhanced (CE) MRI of BME,2022 with chronic compression developed in other animal models of DDD.2325 As a positive control, we used TNF-Tg mice,26 which over produce TNF and develop a systemic autoimmune response phenotype typically seen in SA27 primarily affecting the axial skeleton and joints. Thus, significant similarities and difference observed between WT and TNF-Tg mice in our model provide insights as to whether or not DDD and SA share a common mechanism in the genesis of endplate BME in affected vertebrae.

Materials and Methods

Animals and Instrumentation

Experiments were performed on 2-month-old, heterozygous TNF-Tg mice obtained from Dr. G. Kollias,26 and their sex matched wild type C57B/6 (WT) littermate controls under IACUC approved protocols as we have previously described.21 In compressive load studies mice were anesthetized with a mixture of ketamine 60mg/kg and xylazine 4mg/kg injected I.P., and fitted with two .028” diameter titanium pins implanted transcutaneously in the center of the 7th and 10th caudal vertebrae. Specified vertebrae were palpated, metallic markers placed, and pre-operative radiographs were obtained to ensure proper placement of each pin. This process of implantation allowed us to produce consistent placement of the pins in the intended caudal vertebrae (Figure 1A). Next, compression rings were attached to the implanted pins, which allowed for chronic loading via manual tightening of four screws around which calibrated springs (2.55 N/mm) were placed (Figure 1B). This device was monitored to ensure maintained loading throughout the trial minimizing the effect stress relaxation due to soft tissue deformation or osteolysis.

Figure 1
Quantification of chronic load-induced bone marrow edema in vertebral endplates of the mouse tail

Magnetic Resonance Imaging

MRI scans were performed on anesthetized mice. Due to unacceptable metal artifacts, implants were removed from instrumented mice prior to, and replaced after, each MRI scan. Mice were placed on the imaging stage with the tail mounted next to a saline phantom in the custom dual RF surface coil (Figure 1C), which had previously been developed to image the mouse ankle and knee joints simultaneously.28 The coils were integrated into a clinical 3 Tesla Siemens Trio MRI (Siemens Medical Solutions, Erlangen, Germany). Pre-contrast MRI, and CE-MRI following retroorbital injection of Gd-DTPA contrast agent (Omniscan, Amersham Health, Oslo, Norway) was performed using the pulse sequences and Osirix DICOM viewer analysis methods described previously.21 The resulting CE-MRI post contrast image allows for the quantification of signal intensities (Figure 1D). The normalized bone marrow intensity (NBMI), was calculated by dividing the intensity of a 2D region of interest (ROI) circle (≈ .65µm2) in the bone marrow by the intensity of a control ROI of saline phantom that is of the same size and distance from the center of the surface coil. This was done for 4 consecutive image slices for a total volume of approximately 416 µm3. The normalized marrow contrast enhancement (NMCE) was calculated by subtracting the signal intensity of the pre-contrast ROI (Figure 1E) from the same ROI post-contrast (Figure 1F), and then normalized for Gd-DTPA dosage variations by dividing this value by the contrast enhancement of a large section of muscle (>3mm3) as previously described.21

Micro Computed Tomography

The 6th through 11th caudal vertebra were harvested and directly placed into 10% neutral buffered formalin for 36 to 48 hours for fixation. Specimens were then placed in 70% ETOH until micro-CT imaging 3–5 days later. Specimens were scanned in a VivaCT 40 (Scanco Medical, Brüttisellen, Switzerland) at an isotropic resolution of 17.5µm in a custom sample holder at 55 kEv, as we have previously described for lumbar vertebrae.29 The data were reconstructed via Scanco software into DICOM files and cortical and trabecular bone volumes were quantified using the standard Scanco software.


After micro-CT acquisition, the specimens were decalcified in 14% EDTA at room temperature (pH adjusted to 7.2) for 28 days. Specimens were then embedded in paraffin and 3µm sections were stained with alcian blue/Orange G (AB/OG) or for tartrate-resistant acid phosphatase as previously described.30 Histomorphometry to quantify the vascular sinus tissue area of the bone marrow (% sinus), the cellularity of the bone marrow (mononuclear cells/mm2), and osteoclasts (multinucleated TRAP+ cells) was performed as previously described.31

Statistical Analysis

Two sided t-tests assuming unequal variances were used to make between group comparisons of CE-MRI, micro-CT, or histomorphometry data at each time point or age. All underlying assumptions of parametric methods were checked and no serious violations were detected. P-values less than 0.05 were considered significant.


Induction of vertebral bone marrow edema: chronic load vs. spondyloarthropathy

Previously, we used longitudinal CE-MRI to characterize the natural history of age related haematopoietic (red) to adipose (yellow) marrow conversion in the lower limb of WT mice, resulting in a decrease in NMCE over time, which does not occur in TNF-Tg mice.21 As a prelude to our chronic load studies, we first performed longitudinal CE-MRI and histology studies on 8-week old uninstrumented WT and TNF-Tg caudal vertebrae (Figure 2A, B) to assess age related marrow conversion in the tail. Consistent with our findings in the tibiae,21 WT caudal vertebrae also displayed a significant decrease in NMCE from 8 to 12-weeks of age, which was sustained thereafter (Figure 2C). In contrast, TNF-Tg caudal vertebrae have increased NMCE after 8-weeks, which remained at an elevated level that was significantly greater than that of WT at 12, 16, 20 and 24 weeks. AB /OG stained histology of caudal vertebrae from 8-week old controls, and 24-week old mice from this study, confirmed the red to yellow marrow conversion in WT, but not TNF-Tg marrow (Figure 2D–G). Also of note is the inflammatory-synovitis of the TNF-Tg joint that is indicative of the SA observed in these animals, and is consistent with the high CE-MRI signal of the surrounding soft tissue.

Figure 2
Age related marrow changes in WT and TNF-Tg caudal vertebrae assessed by CE-MRI and histology

In order to design a study to assess the effects of chronic compressive loads on BME in caudal vertebrae using our model, we first performed pilot studies with various loads (1X, 6X, 12X body weight) to identify the maximum compressive force that did not cause significant tissue damage (i.e. vertebral fracture and soft tissue necrosis). This study indicated that 6X body weight was ideal for our model (data not shown). Thus, we assessed the effects of 6X load on BME in WT and TNF-Tg mice, and compared the results to 0X loaded WT controls (Figure 3). The results demonstrated that the load significantly increased NMCE in WT vertebrae at 2-weeks, and remained significantly elevated from baseline throughout the study. Interestingly, the NMCE in 6X WT vertebrae achieved an equivalent signal to that of 6X TNF-Tg after 4 weeks of chronic load, and remained at this significantly elevated level thereafter. Remarkably, in contrast to WT, the 6X chronic load failed to increase BME in TNF-Tg vertebrae above that observed from the SA at baseline.

Figure 3
Chronic compression induces BME in WT but does not significantly increase BME in TNF-Tg caudal vertebrae

Effects of chronic load vs. SA on vertebral bone, marrow elements and osteoclasts

As bone is responsive to mechanical load, and these changes could have been directly or indirectly responsible for the BME signal we observed by MRI, we evaluated the properties of the cortical and trabecular bone from the experimental vertebrae of the WT and TNF-Tg mice (Figure 4). Consistent with previous reports of SA-induced osteopenia in TNF-Tg sacral27 and lumbar29 vertebrae, we found that TNF-Tg caudal vertebrae had significantly less cortical bone volume, cortical bone thickness, and trabecular bone volume fraction vs. WT (Figure 4G–I). Interestingly, analyses of 6X loaded WT vertebra harvested over time demonstrated a biphasic pattern of bone loss followed by an increase bone, found in all three measurements (Figure 4J–L). While these are not longitudinal experiments the results suggest that the chronic load induced a compensatory bone remodeling. To investigate this we analyzed histology of the experimental vertebrae (Figure 5). Assessment of the AB/OG stained 0X vs. 6X WT histology revealed several remarkable differences. The unloaded intervertebral discs had fully expanded and seemingly well hydrated nucleus pulposus, the annulus organization was well separated and with distinct layers, and the separation between the two regions was well defined with high proteoglycan content (Figure 5A). In contrast, the loaded vertebrae displayed compressed nucleus pulposus, the annulus appeared ruptured, compressed, and asymmetric, and the distinction between the two regions along the lateral periphery was poorly defined (Figure 5C). Although synovitis was present in the 6X WT vertebrae, it was much less severe versus the AS in the TNF-Tg, and not dramatically different from that observed in the unloaded WT. Thus, these soft tissue changes are consistent with other models of DDD.

Figure 4
Spondyloarthropathy, but not chronic compression induces cortical and trabecular bone loss
Figure 5
Chronic compression induces increase in vascular sinus and cellularity in subchondral bone marrow

As the primary objective of this study was to investigate the nature of load-induced BME, we performed histomorphometry to quantify the cellular and vascular compartments of the marrow. Consistent with our prior observations of arthritis-induced NMCE in the mouse knee, the increased BME signal in the 6X WT vertebrae corresponded to red marrow (monocytes and vascular sinuses), which was scant in other regions of the bone and absent in the adipocyte filled 0X WT vertebrae. Histomorphometry confirmed the significant load-induced increases in marrow cellularity and vascular tissue (Figure 5G,H). While these marrow changes were similar to that observed in 6X TNF-Tg vertebrae, explaining the similar NMCE values, we also noticed that the 6X WT vertebrae lacked the focal erosions that were apparent in TNF-Tg endplates. To further evaluate this difference, we used TRAP stained histology to investigate osteoclast formation (Figure 6A–F). We observed a modest increase in TRAP positive stained osteoclasts in 6X WT vertebral sections as compared to 0X WT controls, suggestive of increased remodeling. However, these osteoclast levels were still less than that observed in 6X TNF-Tg, which was consistent with the AS-induced focal erosions and osteopenia observed by micro-CT.

Figure 6
Chronic compression induces a modest increase in osteoclast formation compared to spondyloarthropathy


One of the greatest difficulties in the clinical management of LBP is identifying quantitative technologies which demonstrate a high degree of correlation with the patient’s clinical condition. There is a critical need for imaging tests that can discriminate between pathologies whose symptoms are addressable by current interventions (e.g. spinal fusion surgery), versus more complicated conditions that are less likely to benefit from high-risk and costly procedures. While assessment of MT1 vs. MT2 changes had been utilized for this purpose, it is done without a formal understating of the corresponding histological and biochemical milieu. Although several groups have published studies attempting to correlate BME signals with patient retrieval tissue obtained during surgery,32,33 the interpretation of these findings is limited by the end-stage tissue that can be analyzed. Thus, in order to elucidate the nature of BME and the cellular and molecular underpinnings of DDD, we have developed this small animal model that allows for longitudinal assessment of chronic load induced changes by CE-MRI, micro-CT and histology. This model has several major shortcomings. First, there is no evidence from this work that the observed changes were in any way painful or symptomatic. It is a well recognized clinical fact that there are many patients with Modic changes in vertebral segments who are clinically asymptomatic. Thus while our model can be used to better understand some of the molecular and histochemical responses to chronic loading of a disc, it does not, at this point, serve to better explain the clinical problem of LBP. Second, the mouse is a quadruped and the tail segment is a less complex articulation than the human functional spinal unit. There are no facet joints in the mouse tail, it is not normally subject to axial loading, and motion in the segment is less constrained than in the human disc. It is not clear whether these anatomic and functional differences result in differences at the molecular level which might compromise our results. Certainly, the differing role of the tail versus the human spine needs to be borne in mind while considering our results. The authors considered these differences in planning this work; however, the actual mouse intervertebral segment is too small to serve as a practical experimental model, and larger animals are not conducive to transgenic experiments. Although this model has weaknesses, it has several advantages that are noteworthy. First, by using mice, this model facilitates the use of transgenic mice to isolate the roles of specific inflammatory mediators in the degenerative process. The value of this facet of the model cannot be overstated, as transgenic experiments are one of the most efficient and specific tools in unraveling complex biologic systems. Moreover, future improvements, such as incorporating outcome measures of painful behavior in mice,34 could enable this model to directly test hypotheses of the cause-effect relationship between BME signals and LBP (e.g. MT1 vs. MT2 changes), and to longitudinally assess experimental therapeutics.

Although an etiological role of TNF has been firmly established in SA,17,18 and has been implicated in the pathogenesis of DDD,1416 the similarities and differences between BME induced by chronic inflammation and compressive load have yet to be described. To address this, we utilized NBMI and NMCE as separate indicators of BME. In contrast to their comparable utility to quantify TNF-induced BME in inflammatory-erosive arthritis,21 here we have found that the NBMI values, which we believe are a function of tissue permeability, are inconsistent and do not progress with incidence of BME induced by chronic compression (data not shown). However, NMCE values, which we believe are a function of tissue vascularity, proved to be a faithful assessment of the chronic load-induced bone marrow cellularity and vascularity (Figure 3 & Figure 5). Thus, while both chronic joint inflammation and compression induce cellular and vascular changes in the bone marrow, which produce equivalent NMCE values, biomechanical load does not appear to increase marrow permeability the way inflammatory arthritis does.

Another remarkable difference that we observed between our models of DDD and SA is their effects on osteoclast numbers and bone (Figure 4 & Figure 5). As predicted from studies of the TNF-Tg spine, chronic inflammation in caudal vertebrae leads to erosions and generalized osteopenia. The absence of inflammatory tissue, lower numbers of osteoclasts and absence of erosions observed in 6X WT mice highlights the contrasting role that TNF plays in SA and its potential role in the generation of BME and LBP in DDD. Future studies to determine if TNF is required for BME using genetically deficient mice, and the effects of anti-TNF therapy in our model are warranted.


The authors would like to thank Ryan Tierney and Michael Thullen for technical assistance with the histology and micro-CT analyses respectively. This work was supported by research grants from Centocor Inc., and the National Institutes of Health PHS awards AR54041, AR/AG48697, AR46545, and AR56702.


1. Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581–585. [PubMed]
2. Deyo RA, Phillips WR. Low back pain. A primary care challenge. Spine. 1996;21(24):2826–2832. [PubMed]
3. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine. 1987;12(3):264–268. [PubMed]
4. Luo X, Pietrobon R, Sun SX, Liu GG, Hey L. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine. 2004;29(1):79–86. [PubMed]
5. Carey TS, Garrett JM, Jackman AM. Beyond the good prognosis. Examination of an inception cohort of patients with chronic low back pain. Spine. 2000;25(1):115–120. [PubMed]
6. Junge A, Frohlich M, Ahrens S, Hasenbring M, Sandler A, Grob D, Dvorak J. Predictors of bad and good outcome of lumbar spine surgery. A prospective clinical study with 2 years' follow up. Spine. 1996;21(9):1056–1064. discussion 64–5. [PubMed]
7. Childs JD, Fritz JM, Flynn TW, Irrgang JJ, Johnson KK, Majkowski GR, Delitto AA. clinical prediction rule to identify patients with low back pain most likely to benefit from spinal manipulation: a validation study. Ann Intern Med. 2004;141(12):920–928. [PubMed]
8. Starr AM, Wessely MA, Albastaki U, Pierre-Jerome C, Kettner NW. Bone marrow edema: pathophysiology, differential diagnosis, and imaging. Acta Radiol. 2008;49(7):771–786. [PubMed]
9. Modic MT, Masaryk TJ, Ross JS, Carter JR. Imaging of degenerative disk disease. Radiology. 1988;168(1):177–186. [PubMed]
10. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR. Degenerative disk disease: assessment of changes in vertebral body marrow with MR imaging. Radiology. 1988;166-1(Pt 1):193–199. [PubMed]
11. Marshman LA, Trewhella M, Friesem T, Bhatia CK, Krishna M. Reverse transformation of Modic type 2 changes to Modic type 1 changes during sustained chronic low-back pain severity. Report of two cases and review of the literature. J Neurosurg Spine. 2007;6(2):152–155. [PubMed]
12. Braithwaite I, White J, Saifuddin A, Renton P, Taylor BA. Vertebral end-plate (Modic) changes on lumbar spine MRI: correlation with pain reproduction at lumbar discography. Eur Spine J. 1998;7(5):363–368. [PubMed]
13. Sandhu HS, Sanchez-Caso LP, Parvataneni HK, Cammisa FP, Jr, Girardi FP, Ghelman B. Association between findings of provocative discography and vertebral endplate signal changes as seen on MRI. J Spinal Disord. 2000;13(5):438–443. [PubMed]
14. Ohtori S, Inoue G, Ito T, Koshi T, Ozawa T, Doya H, Saito T, Moriya H, Takahashi K. Tumor necrosis factor-immunoreactive cells and PGP 9.5-immunoreactive nerve fibers in vertebral endplates of patients with discogenic low back Pain and Modic Type 1 or Type 2 changes on MRI. Spine. 2006;31(9):1026–1031. [PubMed]
15. Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllonen E, Lindgren KA, Rantanen P, Tervonen O, Niinimaki J, Seitsalo S, Hurri H. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine. 2003;28(8):750–753. discussion 3–4. [PubMed]
16. Cohen SP, Bogduk N, Dragovich A, Buckenmaier CC, 3rd, Griffith S, Kurihara C, Raymond J, Richter PJ, Williams N, Yaksh TL. Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica. Anesthesiology. 2009;110(5):1116–1126. [PubMed]
17. Braun J, Landewe R, Hermann KG, Han J, Yan S, Williamson P, van der Heijde D. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum. 2006;54(5):1646–1652. [PubMed]
18. van der Heijde D, Han C, DeVlam K, Burmester G, van den Bosch F, Williamson P, Bala M, Han J, Braun J. Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Rheum. 2006;55(4):569–574. [PubMed]
19. Modic MT. Modic type 1 and type 2 changes. J Neurosurg Spine. 2007;6(2):150–151. discussion 1. [PubMed]
20. Proulx ST, Kwok E, You Z, Beck CA, Shealy DJ, Ritchlin CT, Boyce BF, Xing L, Schwarz EM. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci. 2007;1117:106–123. [PubMed]
21. Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, Calvi LM, Ritchlin CT, Awad HA, Boyce BF, Xing L, Schwarz EM. Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast-enhanced magnetic resonance imaging. Arthritis Rheum. 2008;58(7):2019–2029. [PMC free article] [PubMed]
22. Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, Ritchlin CT, Awad HA, Boyce BF, Xing L, Schwarz EM. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum. 2007;56(12):4024–4037. [PMC free article] [PubMed]
23. Stokes IA, Aronsson DD, Spence H, Iatridis JC. Mechanical modulation of intervertebral disc thickness in growing rat tails. J Spinal Disord. 1998;11(3):261–265. [PubMed]
24. Stokes IA, Spence H, Aronsson DD, Kilmer N. Mechanical modulation of vertebral body growth. Implications for scoliosis progression. Spine. 1996;21(10):1162–1167. [PubMed]
25. Lotz JC, Ulrich JA. Innervation, inflammation, and hypermobility may characterize pathologic disc degeneration: review of animal model data. J Bone Joint Surg Am. 2006;88 Suppl 2:76–82. [PubMed]
26. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. Embo J. 1991;10(13):4025–4031. [PubMed]
27. Redlich K, Gortz B, Hayer S, Zwerina J, Kollias G, Steiner G, Smolen JS, Schett G. Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum. 2004;50(3):1001–1005. [PubMed]
28. Guo R, Zhou Q, Proulx ST, Wood R, Ji RC, Ritchlin CT, Pytowski B, Zhu Z, Wang YJ, Schwarz EM, Xing L. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum. 2009;60(9):2666–2676. [PMC free article] [PubMed]
29. Guo R, Yamashita M, Zhang Q, Zhou Q, Chen D, Reynolds DG, Awad HA, Yanoso L, Zhao L, Schwarz EM, Zhang YE, Boyce BF, Xing L. Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins. J Biol Chem. 2008;283(34):23084–23092. [PubMed]
30. Tsutsumi R, Hock C, Bechtold CD, Proulx ST, Bukata SV, Ito H, Awad HA, Nakamura T, O'Keefe RJ, Schwarz EM. Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. J Orthop Res. 2008;26(10):1340–1346. [PMC free article] [PubMed]
31. Tiyapatanaputi P, Rubery PT, Carmouche J, Schwarz EM, O'Keefe RJ, Zhang XA. novel murine segmental femoral graft model. J Orthop Res. 2004;22(6):1254–1260. [PubMed]
32. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum. 2007;56(4):1118–1124. [PubMed]
33. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, Stein H, Metz-Stavenhagen P, Rudwaleit M, Sieper J. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther. 2006;8(5):R143. [PMC free article] [PubMed]
34. Walker K, Fox AJ, Urban LA. Animal models for pain research. Mol Med Today. 1999;5(7):319–321. [PubMed]